Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.447NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.447NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.447NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.110.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.110.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.110.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.180NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.180NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.180NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.155NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.155NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.155NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.92NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.92NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.92NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.145NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.145NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.145NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.120NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.120NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.120NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.77NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.77NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.77NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AE.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AE.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AE.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.504NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.504NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.504NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AE.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AE.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AE.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.201NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.201NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.201NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.221NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.221NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.221NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.410NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.410NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.410NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.411NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.411NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.513NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.513NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.513NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.338NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.338NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.338NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used